iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference
06 nov. 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
05 nov. 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 05, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
iCAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
03 oct. 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H. and PARIS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, today...
iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
11 sept. 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
13 août 2024 16h01 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically...
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
06 août 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial...
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
29 juil. 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C., July 29, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, today...
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
26 juin 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research...
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
04 juin 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
15 mai 2024 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...